1. Home
  2. MDBH vs VNRX Comparison

MDBH vs VNRX Comparison

Compare MDBH & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MDB Capital Holdings LLC common

MDBH

MDB Capital Holdings LLC common

HOLD

Current Price

$3.63

Market Cap

36.7M

Sector

N/A

ML Signal

HOLD

Logo VolitionRX Limited

VNRX

VolitionRX Limited

HOLD

Current Price

$0.36

Market Cap

38.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDBH
VNRX
Founded
1997
N/A
Country
United States
United States
Employees
40
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.7M
38.2M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
MDBH
VNRX
Price
$3.63
$0.36
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$2.50
AVG Volume (30 Days)
14.7K
2.1M
Earning Date
11-13-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.76
N/A
Revenue
$1,250,398.00
$1,472,007.00
Revenue This Year
N/A
$55.98
Revenue Next Year
N/A
$420.37
P/E Ratio
$4.75
N/A
Revenue Growth
N/A
14.48
52 Week Low
$3.11
$0.22
52 Week High
$7.98
$0.94

Technical Indicators

Market Signals
Indicator
MDBH
VNRX
Relative Strength Index (RSI) 53.11 67.56
Support Level $3.11 $0.22
Resistance Level $3.69 $0.28
Average True Range (ATR) 0.19 0.02
MACD 0.03 0.01
Stochastic Oscillator 70.69 81.53

Price Performance

Historical Comparison
MDBH
VNRX

About MDBH MDB Capital Holdings LLC common

MDB Capital Holdings LLC is an investment holding company that operates through its subsidiaries and focuses on early-stage technology companies through public offerings. The company's purpose is to engage with companies holding visionary technology, inventors, and technology entrepreneurs. The Company operates in two reportable segments: a broker dealer & intellectual property service, and the technology development segment. The broker dealer & intellectual property service segment, which derives key revenue, is engaged in conducting private and public securities offerings and offers in-depth patent research used for investment banking due diligence.

About VNRX VolitionRX Limited

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

Share on Social Networks: